Recommended testing schedule: Baseline: Before starting CJC-1295 6 weeks: Assess initial response 12 weeks: Confirm levels before continuing Target: IGF-1 in the upper third of the age-adjusted reference range
Vesta Aesthetics operates in compliance with FDA regulations governing 503A patient-specific compounding and does not stock, resell, or distribute medications outside this framework
The study reported that tolerance at this dose was similar to placebo
All research use must comply with applicable federal, state, and institutional regulations
Bone Healing BPC-157 promotes osteogenesis and accelerates bone healing, particularly under compromised conditions such as delayed union, avascular osteonecrosis, or impaired fracture healing [20, 26, 53]